#7Wonders
WHO recommends two Bundibugyo Ebola vaccines for the DRC trial
Two new Bundibugyo Ebola vaccines will enter a live trial during the DRC outbreak.
6 Nov 2026, 06:19 · All sides · Written by Grok
12 sources · 4 countries🇺🇳 🇬🇧 🇶🇦 🇪🇺 🇺🇸
- WHO expert groups have recommended that two vaccines aimed at the Bundibugyo type of Ebola join a study already running in the Democratic Republic of the Congo.
- It would be the first time vaccines made for this strain are tested during an active outbreak.
- Results are expected in early 2027.
How the views differ
State media, independent media and top voices on X
International public-health officials and trial partners highlighting scientific progress
Officials treat the recommendation as proof that science and partnership can move fast enough to test the right vaccines during an active outbreak.
They stress that shots built for Bundibugyo, not only for the Zaire strain, will be studied while cases are still spreading.
They also say vaccines will not end the outbreak by themselves.
- who.int (Ind.)
- news.un.org (Ind.)
- aljazeera.com (St.)
- afp.com (Ind.)
Cautious outbreak-response voices and critics of vaccine-first priorities
Cautious responders argue that contact tracing, isolation, safe burials, early care and community trust are what cut deaths in an Ebola outbreak.
They point to a fatality rate already near 50%, a toll still in the thousands, and results not expected until early 2027.
Some also question whether research attention is running ahead of basic treatment, and whether speed and ethics are settled in a high-fatality outbreak.
- aljazeera.com (St.)
- data.one.org (Ind.)
- bloomberg.com (Ind.)
- @P_McCulloughMD (X)
- telegraph.co.uk (Ind.)
- healthpolicy-watch.news (Ind.)
- View B — Peter A. McCullough, MD (@P_McCulloughMD): “Instead of working on sanitation and assisting in basic supportive intravenous fluids, antiemetics, and antidiarrheals, the WHO and MSM media are exploiting the DRC and…” Open on X ↗
The recommendation itself is well supported. WHO, UN News and Al Jazeera all report that expert groups want ChAdOx1 BDBV and mRNA-1469 added to the Tumaini trial, led by DRC’s national research institute. Some headlines say WHO “approved” or “greenlit” the trials. That matches the same reported decision; the more precise official wording is a recommendation to add the candidates to a trial already under way.
Grey areas. Ask to dive deeper
Grok checks every side again and answers with sources.
Popular questions
Ask anything about this story. It's free with an account, 1 a week.
- May 2026
The Democratic Republic of the Congo declares an Ebola outbreak, the 17th in its history.
- 2026
The Tumaini trial begins in the Democratic Republic of the Congo, including the Ervebo vaccine.
Coverage
12 sources · 6 countries
- State-funded 10
- Independent 1
- X / on the ground 1
UNGBQAEUUSFR
All sources
- WHO (independent international)The candidates are ChAdOx1 BDBV, from the University of Oxford and the Serum Institute of India, and Moderna’s mRNA-1469. WHO UN NewsState-funded · United Nations
- UN News (independent international)The candidates are ChAdOx1 BDBV, from the University of Oxford and the Serum Institute of India, and Moderna’s mRNA-1469. WHO UN NewsState-funded · United Nations
- SourcesThe outbreak, declared in May 2026 and the 17th in DRC history, has reported totals above 10,400–10,668 confirmed cases and above 5,198–5,372 deaths, a fatality rate of about 48.6–51.6%. Al Jazeera ONE ECDC BloombergState-funded · Qatar
- data.one.orgThe outbreak, declared in May 2026 and the 17th in DRC history, has reported totals above 10,400–10,668 confirmed cases and above 5,198–5,372 deaths, a fatality rate of about 48.6–51.6%. Al Jazeera ONE ECDC BloombergState-funded
- ecdc.europa.euThe outbreak, declared in May 2026 and the 17th in DRC history, has reported totals above 10,400–10,668 confirmed cases and above 5,198–5,372 deaths, a fatality rate of about 48.6–51.6%. Al Jazeera ONE ECDC BloombergState-funded · European Union
- Bloomberg (independent international)The outbreak, declared in May 2026 and the 17th in DRC history, has reported totals above 10,400–10,668 confirmed cases and above 5,198–5,372 deaths, a fatality rate of about 48.6–51.6%. Al Jazeera ONE ECDC BloombergState-funded · United States
- SourcesSources: WHO (independent international) ; UN News (independent international) ; Al Jazeera (independent international) ; AFP (independent international)State-funded · France
- @P_McCulloughMDA physician critic says the focus looks like market preparation for another Ebola vaccine rather than sanitation and basic supportive care. X postX / on the ground
- telegraph.co.ukEarlier reporting described ethics disputes over Ebola drug trials; that record is about earlier studies, not a finding about this vaccine decision. The TelegraphState-funded · United Kingdom
- healthpolicy-watch.newsSources: Al Jazeera; Health Policy Watch; Peter A. McCullough, MD; The TelegraphState-funded
- Africa CDC (regional African organization) (and related)africacdc.orgIndependent
- BBC News (independent international)bbc.co.ukState-funded · United Kingdom